<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Avecho Biotechnology Limited — News on 6ix</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd</link>
<description>Latest news and press releases for Avecho Biotechnology Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 12 May 2026 05:15:08 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/avecho-biotechnology-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836614578dffbe2df15bea7.webp</url>
<title>Avecho Biotechnology Limited</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd</link>
</image>
<item>
<title>Expiry of Listed Options</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/expiry-of-listed-options</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/expiry-of-listed-options</guid>
<pubDate>Tue, 12 May 2026 05:15:08 GMT</pubDate>
<description>Expiry of Listed Options</description>
</item>
<item>
<title>March 2026 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/march-2026-quarterly-activities-report-and-appendix-4c-5</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/march-2026-quarterly-activities-report-and-appendix-4c-5</guid>
<pubDate>Wed, 29 Apr 2026 02:53:18 GMT</pubDate>
<description>March 2026 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Avecho completes recruitment for Phase III interim analysis</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-completes-recruitment-for-phase-iii-interim-analysis</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-completes-recruitment-for-phase-iii-interim-analysis</guid>
<pubDate>Mon, 02 Mar 2026 03:43:17 GMT</pubDate>
<description>Avecho completes recruitment for Phase III interim analysis</description>
</item>
<item>
<title>Annual Report 31 December 2025</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/annual-report-31-december-2025</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/annual-report-31-december-2025</guid>
<pubDate>Fri, 27 Feb 2026 10:25:09 GMT</pubDate>
<description>Annual Report 31 December 2025</description>
</item>
<item>
<title>December 2025 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/december-2025-quarterly-activities-report-and-appendix-4c-5</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/december-2025-quarterly-activities-report-and-appendix-4c-5</guid>
<pubDate>Thu, 29 Jan 2026 08:15:08 GMT</pubDate>
<description>December 2025 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Phase III CBD Clinical Trial Recruitment Update</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/phase-iii-cbd-clinical-trial-recruitment-update</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/phase-iii-cbd-clinical-trial-recruitment-update</guid>
<pubDate>Thu, 18 Dec 2025 04:53:13 GMT</pubDate>
<description>Phase III CBD Clinical Trial Recruitment Update</description>
</item>
<item>
<title>AVE Secures US & EU Patent Allowances for CBD Soft-Gel</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/ave-secures-us-and-eu-patent-allowances-for-cbd-soft-gel</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/ave-secures-us-and-eu-patent-allowances-for-cbd-soft-gel</guid>
<pubDate>Wed, 03 Dec 2025 05:53:02 GMT</pubDate>
<description>AVE Secures US & EU Patent Allowances for CBD Soft-Gel</description>
</item>
<item>
<title>September 2025 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/september-2025-quarterly-activities-report-and-appendix-4c-5</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/september-2025-quarterly-activities-report-and-appendix-4c-5</guid>
<pubDate>Fri, 31 Oct 2025 06:16:05 GMT</pubDate>
<description>September 2025 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Avecho raises $2.5m via placement</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-raises-dollar25m-via-placement</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-raises-dollar25m-via-placement</guid>
<pubDate>Thu, 23 Oct 2025 02:15:14 GMT</pubDate>
<description>Avecho raises $2.5m via placement</description>
</item>
<item>
<title>Appendix 4D and Half-year Financial Report</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/appendix-4d-and-half-year-financial-report-92</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/appendix-4d-and-half-year-financial-report-92</guid>
<pubDate>Thu, 28 Aug 2025 09:37:16 GMT</pubDate>
<description>Appendix 4D and Half-year Financial Report</description>
</item>
<item>
<title>Sleep Health Week: Researchers Recruiting Now for CBD Insomnia Trial</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/sleep-health-week-researchers-recruiting-now-for-cbd-insomnia-trial</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/sleep-health-week-researchers-recruiting-now-for-cbd-insomnia-trial</guid>
<pubDate>Tue, 12 Aug 2025 00:32:00 GMT</pubDate>
<description>Avecho Biotechnology Limited (Avecho) is today alerting Australians to recruitment efforts for the largest ever clinical trial ('the Trial') for the treatment of insomnia with a pharmaceutical cannabidiol (CBD) product – with clinical trial sites now live across the country.</description>
</item>
<item>
<title>June 2025 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/june-2025-quarterly-activities-report-and-appendix-4c-5</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/june-2025-quarterly-activities-report-and-appendix-4c-5</guid>
<pubDate>Wed, 30 Jul 2025 03:05:15 GMT</pubDate>
<description>June 2025 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Phase III Insomnia Trial Recruitment Update</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/phase-iii-insomnia-trial-recruitment-update</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/phase-iii-insomnia-trial-recruitment-update</guid>
<pubDate>Tue, 29 Jul 2025 03:29:16 GMT</pubDate>
<description>Phase III Insomnia Trial Recruitment Update</description>
</item>
<item>
<title>Receipt of R&D Tax Incentive</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/receipt-of-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/receipt-of-randd-tax-incentive</guid>
<pubDate>Wed, 28 May 2025 05:45:09 GMT</pubDate>
<description>Receipt of R&D Tax Incentive</description>
</item>
<item>
<title>Phase III Trial Update - New Sites Commence Recruitment</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/phase-iii-trial-update-new-sites-commence-recruitment</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/phase-iii-trial-update-new-sites-commence-recruitment</guid>
<pubDate>Tue, 20 May 2025 03:23:16 GMT</pubDate>
<description>Phase III Trial Update - New Sites Commence Recruitment</description>
</item>
<item>
<title>March 2025 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/march-2025-quarterly-activities-report-and-appendix-4c-7</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/march-2025-quarterly-activities-report-and-appendix-4c-7</guid>
<pubDate>Wed, 30 Apr 2025 04:28:20 GMT</pubDate>
<description>March 2025 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Avecho receives initial US$3M upfront payment from Sandoz</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-receives-initial-usdollar3m-upfront-payment-from-sandoz</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-receives-initial-usdollar3m-upfront-payment-from-sandoz</guid>
<pubDate>Fri, 28 Mar 2025 02:42:16 GMT</pubDate>
<description>Avecho receives initial US$3M upfront payment from Sandoz</description>
</item>
<item>
<title>Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-sandoz-enter-exclusive-license-220000509</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-sandoz-enter-exclusive-license-220000509</guid>
<pubDate>Mon, 03 Mar 2025 22:00:00 GMT</pubDate>
<description>Avecho Biotechnology Limited (ASX: AVE) ("Avecho" or the "Company") today announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG ("Sandoz") for the commercial rights to Avecho's Phase III cannabidiol ("CBD") capsule for insomnia in Australia. Avecho retains the rights to commercialise the product in all other territories, with Sandoz granted a first right of refusal for these markets. Avecho's CBD capsule aims to be the first pharmaceutical CBD pro</description>
</item>
<item>
<title>Avecho & Sandoz Sign Deal to Develop CBD for Insomnia in AUS</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-and-sandoz-sign-deal-to-develop-cbd-for-insomnia-in-aus</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/avecho-and-sandoz-sign-deal-to-develop-cbd-for-insomnia-in-aus</guid>
<pubDate>Mon, 03 Mar 2025 04:07:13 GMT</pubDate>
<description>Avecho & Sandoz Sign Deal to Develop CBD for Insomnia in AUS</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/avecho-biotechnology-ltd/news/trading-halt-971</link>
<guid isPermaLink="true">https://6ix.com/company/avecho-biotechnology-ltd/news/trading-halt-971</guid>
<pubDate>Fri, 28 Feb 2025 03:13:25 GMT</pubDate>
<description>Trading Halt</description>
</item>
</channel>
</rss>